Please login to the form below

Not currently logged in
Email:
Password:

Emotive grows medical writing capacity

Dr Silvana Bardelli and Dr Ann Gilliat join the agency

Dr Gilliat and Dr BardelliHealthcare Communications agency Emotive has strengthened its medical writing team with the addition of two new hires.

Dr Silvana Bardelli (pictured right) joins as a senior medical writer following a five year career at the Italian Medicines Agency serving as its young European Assessor.

Prior to this she worked at the Swiss Institute for Regenerative Medicine as its project manager and scientific medical writer.

Also joining the medical writing team is Dr Ann Gilliat (pictured left), who joins Emotive as an associate medical writer.

Her career to date has seen her publish several clinical papers over the past three years and she has been involved in various ageing awareness activities.

Dr Gill Boucher, medical director, Emotive, said: “As we continue to deliver even more scientific engagement activities for our medical clients around the world, this is an exciting time to have experienced medical writers join our growing team.

“We are an agency with a very strong heritage in the flawless delivery of complex science to multiple stakeholder groups, and with the arrival of Silvana and Ann, we look forward to further strengthening the level of excellence that we can offer our clients.”

29th November 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dovetail

We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...